Table 2.
Cardiomyopathies global | Morphological anomaly | Functional anomaly | ||||
Hypertrophic | Dilated | Mixed | Non-classified | Non-classifiable | ||
N=182, n (%) | N=27, n (%) | N=114, n (%) | N=27, n (%) | N=1, n (%) | N=13, n (%) | |
Identified aetiologies | 53 (29.1) | 10 (37.0) | 28 (24.6) | 8 (29.6) | 1 (100.0) | 6 (46.2) |
Aetiological explorations negative | 56 (30.8) | 5 (18.5) | 43 (37.7) | 6 (22.2) | 0 (0.0) | 2 (15.3) |
Aetiological explorations not performed | 35 (19.3) | 7 (26.0) | 19 (16.6) | 8 (29.6) | 0 (0.0) | 1 (7.7) |
No explorations synthesis | 33 (18.1) | 5 (18.5) | 21 (18.4) | 4 (14.8) | 0 (0.0) | 3 (23.1) |
Aetiological doubt | 2 (1.1) | 0 (0.0) | 1 (0.9) | 0 (0.0) | 0 (0.0) | 1 (7.7) |
Other causes of non-identification* | 3 (1.6) | 0 (0.0) | 2 (1.8) | 1 (3.8) | 0 (0.0) | 0 (0.0) |
*Explorations done in mainland France; serologies not recontroled and results not found.